The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
octinoxate, octocrylene, and titanium dioxide · Powder
8 marketed package NDCs · 1 active manufacturer
Most dispensed: 2010 mg/30mL; 900 mg/30mL; TITANIUM DIOXIDE 600 mg/30mL · Emulsion · #1 tube/container / 30 ml in 1 tube · 888 mg/12g; 600 mg/12g; TITANIUM DIOXIDE 1416 mg/12g · Powder · #1 tray/carton / 12 g in 1 tray
Common questions
- Is Octinoxate, octocrylene, and titanium dioxide in shortage right now?
- No. FDA does not currently list Octinoxate, octocrylene, and titanium dioxide in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Octinoxate, octocrylene, and titanium dioxide?
- 1 company has marketed Octinoxate, octocrylene, and titanium dioxide in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.